| abstract |
The present invention provides a pharmaceutical composition alcohol body, comprising the following components by weight percentage: thymosin beta 40.1-0.2%, glucocorticoid 0.5-1%, low molecular weight alcohol 30-50%, phospholipid 3.0- 12.0%, cholesterol 1.0-2.5%, adjuvant 0.51-1.3%, and the rest are PBS buffer. The present invention also provides a method for preparing an alcohol body of a pharmaceutical composition for treating scars. The alcohol body of the present invention can reduce the dosage of hormones, reduce the generation of side effects, and have a more lasting therapeutic effect. In addition to the scar atrophy during the medication process, the scar is not easy to recur after the medication is stopped, and the effect of 1+1>2 is achieved. The alcohol body of the invention has strong transdermal ability, high encapsulation rate, large drug loading capacity, good stability, and is easy to store and use. In addition, the alcohol plastid of the present invention has the advantages of convenient administration, safety, controllability, good compliance, and higher bioavailability. |